Does Capital Advantage Insurance Company require prior authorization for Intralipid?
Prior authorization for Intralipid differs across Capital Advantage Insurance Company's Medicare Part D plans and product strengths — 1 of 2 Intralipid products in the corpus appear on their formularies, and the requirement is not uniform. Check the member's specific plan.
Some plans require authorization and others do not. The member's specific plan decides.
By product strength
| RxNorm product | Plans covering | Require prior auth | Status |
|---|---|---|---|
| 250 ML soybean oil 200 MG/ML Injection [Intralipid]1799706 | 23 / 23 | 23 | Prior authorization required |
| soybean oil 300 MG/ML Injectable Suspension [Intralipid]805131 | 0 / 23 | 0 | Not on formulary |
Product names come from RxNorm (U.S. National Library of Medicine).
- Effective
- 2026-06-30
- Retrieved
- 2026-07-19
- SHA-256
- e626e6bcda1aa6a0071e6f0df6bafe686ae41842cdf0a9feffdc649b6d3ff3ae
We publish the hash of the exact file we ingested so any answer can be audited against the bytes CMS served that day.
Intralipid at other payers
Administrative information only. Benefily reports what a payer has published in its own prior-authorization policy as of the effective date shown. It is not medical advice, not a coverage or payment guarantee, and not an authorization. Requirements vary by plan, place of service and member benefits — always verify with the payer before rendering service.